Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Minicells overcome tumor drug-resistance

Nature Biotechnology volume 27, pages 620–621 (2009)Cite this article

Bacterially derived minicells loaded with siRNA reverse drug resistance in tumor xenografts.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Bacterially derived minicells can deliver siRNA and plasmid-encoded shRNA to reverse tumor drug resistance in vivo.

References

  1. Chabner, B.A. & Roberts, T.G. Jr. Nat. Rev. Cancer 5, 65–72 (2005).

    Article  CAS  Google Scholar 

  2. MacDiarmid, J.A. et al. Nat. Biotechnol. 27, 643–651 (2009).

    Article  CAS  Google Scholar 

  3. Rubin, B.P. & Duensing, A. Lab. Invest. 86, 981–986 (2006).

    Article  CAS  Google Scholar 

  4. Gottesman, M.M. et al. Nat. Rev. Cancer 2, 48–58 (2002).

    Article  CAS  Google Scholar 

  5. Jain, R.K. Adv. Drug Deliv. Rev. 46, 149–168 (2001).

    Article  CAS  Google Scholar 

  6. Peer, D. et al. Nat. Nanotechnol. 2, 751–760 (2007).

    Article  CAS  Google Scholar 

  7. Langer, R. Nature 392, 5–10 (1998).

    CAS  PubMed  Google Scholar 

  8. MacDiarmid, J.A. et al. Cell Cycle 6, 2099–2105 (2007).

    Article  CAS  Google Scholar 

  9. MacDiarmid, J.A. et al. Cancer Cell 11, 431–445 (2007).

    Article  CAS  Google Scholar 

  10. Whitehead, K.A. et al. Nat. Rev. Drug Discov. 8, 129–138 (2009).

    Article  CAS  Google Scholar 

  11. Aouadi, M. et al. Nature 458, 1180–1184 (2009).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Emmanouil D. Karagiannis and Daniel G. Anderson are at the David H. Koch Institute for Integrated Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.,

    Emmanouil D Karagiannis & Daniel G Anderson

Authors
  1. Emmanouil D Karagiannis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Daniel G Anderson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Daniel G Anderson.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Karagiannis, E., Anderson, D. Minicells overcome tumor drug-resistance. Nat Biotechnol 27, 620–621 (2009). https://doi.org/10.1038/nbt0709-620

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0709-620

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing